Wagner Paul A. — SEC insider filings
SEC reporting owner CIK 1612842. 31 insider filings on record with FilingPulse; latest filed 2026-08-27.
Transaction summary — filings shown
Covers all 31 filings on record, filed 2021-04-13 to 2026-08-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 13 legs across 6 filings — 218,865 shares, $179,712 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,000,000 shares, $4,347,100 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 63.
- Largest priced transaction: sale of 1,000,000 shares @ $4.35 ($4,347,100) in Forte Biosciences, Inc., filed 2021-09-08.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Forte Biosciences, Inc. (FBRX) | SEE REMARKS, Director | 31 | 13 legs · 218,865 sh · $179,712 | 1 leg · 1,000,000 sh · $4,347,100 | 63 |
Insider filings — Wagner Paul A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-27 | 4 | Forte Biosciences, Inc. (FBRX) | Code (U): 85,482 · Disposition to issuer (D): 16,866 (derivative) · Disposition to issuer (D): 5,400 (derivative) · Disposition to issuer (D): 11,999 (derivative) · Disposition to issuer (D): 44,000 (derivative) · Disposition to issuer (D): 920,000 (derivative) · +5 more | EDGAR |
| 2026-07-06 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 · Tax withholding (F): 98 @ $21.32 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 · Tax withholding (F): 98 @ $24.86 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2026-01-13 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 270,000 (derivative) @ $0 · Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2026-01-02 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 164 @ $27.27 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $14.52 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-07-03 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $12.44 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 18 @ $7.43 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 920,000 (derivative) @ $0 | EDGAR |
| 2025-01-02 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 164 @ $22.71 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 1,250 @ $0 · Tax withholding (F): 98 @ $5.16 · Option exercise (M): 1,250 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $0.55 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2024-04-02 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $0.71 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 1,100,000 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 31,250 @ $0 · Tax withholding (F): 4,109 @ $0.82 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2023-12-20 | 4 | Forte Biosciences, Inc. (FBRX) | Purchase (P): 10,000 @ $0.75 | EDGAR |
| 2023-12-15 | 4 | Forte Biosciences, Inc. (FBRX) | Purchase (P): 10,520 @ $0.70 · Purchase (P): 10,000 @ $0.72 | EDGAR |
| 2023-12-12 | 4 | Forte Biosciences, Inc. (FBRX) | Purchase (P): 25,000 @ $0.65 · Purchase (P): 4,776 @ $0.65 | EDGAR |
| 2023-12-08 | 4 | Forte Biosciences, Inc. (FBRX) | Purchase (P): 36,203 @ $0.58 · Purchase (P): 15,000 @ $0.62 | EDGAR |
| 2023-11-22 | 4 | Forte Biosciences, Inc. (FBRX) | Purchase (P): 5,300 @ $0.44 · Purchase (P): 1,566 @ $0.43 · Purchase (P): 100 @ $0.43 · Purchase (P): 400 @ $0.43 | EDGAR |
| 2023-10-03 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $0.66 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2023-08-02 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 247,524 @ $1.01 | EDGAR |
| 2023-07-05 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 31,250 @ $0 · Tax withholding (F): 2,453 @ $1.04 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Forte Biosciences, Inc. (FBRX) | Option exercise (M): 31,250 @ $0 · Tax withholding (F): 11,046 @ $1.01 · Option exercise (M): 31,250 (derivative) @ $0 | EDGAR |
| 2023-03-23 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2022-12-19 | 4 | Forte Biosciences, Inc. (FBRX) | Purchase (P): 55,976 @ $1.03 · Purchase (P): 44,024 @ $1.07 | EDGAR |
| 2022-05-16 | 4 | Forte Biosciences, Inc. (FBRX) | Disposition to issuer (D): 40,000 (derivative) @ $0 | EDGAR |
| 2022-01-18 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2021-09-08 | 4 | Forte Biosciences, Inc. (FBRX) | Sale (S): 1,000,000 @ $4.35 | EDGAR |
| 2021-04-13 | 4 | Forte Biosciences, Inc. (FBRX) | Grant/award (A): 175,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-07 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1612842 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs